Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia

Atherosclerosis

Volumn 243, Issue 1, 2015, Pages 155-160

  Narverud, Ingunn ^a,b   Van Lennep, Jeanine Roeters ^c   Christensen, Jacob J ^a,b   Versmissen, Jorie ^c   Gran, Jon Michael ^a   Iversen, Per Ole ^a,d   Aukrust, Pål ^a,b,e,g   Halvorsen, Bente ^a,b,e   Ueland, Thor ^a,b,e,g   Ulven, Stine M ^f   Ose, Leiv ^a,b   Veierød, Marit B ^a   Sijbrands, Eric ^c   Retterstøl, Kjetil ^a,b   Holven, Kirsten B ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e KG Jebsen Inflammatory Research Center   (Norway)

^f OSLO METROPOLITAN UNIVERSITY   (Norway)

^g UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Children; Familial hypercholesterolemia; LDL cholesterol; Maternal inheritance

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CHILD; EXTRACHROMOSOMAL INHERITANCE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; HUMAN; INFANT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; PRIORITY JOURNAL; BLOOD; DNA MUTATIONAL ANALYSIS; FATHER; GENETICS; HEREDITY; INFLAMMATION; METABOLISM; MOTHER; MUTATION; NORWAY; PHENOTYPE; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DNA MUTATIONAL ANALYSIS; FATHERS; FEMALE; HEREDITY; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INFANT; INFANT, NEWBORN; INFLAMMATION; LIPIDS; MALE; MOTHERS; MUTATION; NORWAY; PHENOTYPE; TRIGLYCERIDES; YOUNG ADULT;

EID: 84942060548     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.09.014     Document Type: Article

References (29)

1. Libby P., Hansson G.K. Adaptive immunity and atherosclerosis. Clin. Immunol. 2010, 134:33-46.
2. Martin U., Davies C., Hayavi S., Hartland A., Dunne F. Is normal pregnancy atherogenic?. Clin. Sci. (Lond) 1999, 96:421-425.
3. Amundsen A.L., Khoury J., Iversen P.O., et al. Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia. Atherosclerosis 2006, 189:451-457.
4. Amundsen A.L., Khoury J., Sandset P.M., et al. Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia. Thromb. Res. 2007, 120:21-27.
5. Palinski W., Yamashita T., Freigang S., Napoli C. Developmental programming: maternal hypercholesterolemia and immunity influence susceptibility to atherosclerosis. Nutr. Rev. 2007, 65:S182-S187.
6. Palinski W., Nicolaides E., Liguori A., Napoli C. Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease. J. Cardiovasc. Transl. Res. 2009, 2:277-285.
7. Napoli C., D'Armiento F.P., Mancini F.P., et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 1997, 100:2680-2690.
8. Napoli C., Glass C.K., Witztum J.L., Deutsch R., D'Armiento F.P., Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study. Lancet 1999, 354:1234-1241.
9. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
10. Austin M.A., Hutter C.M., Zimmern R.L., Humphries S.E. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am. J. Epidemiol. 2004, 160:407-420.
11. Weisgraber K.H., Innerarity T.L., Newhouse Y.M., Young S.G., Arnold K.S., Krauss R.M., Vega G.L., Grundy S.M., Mahley R.W. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:9758-9762.
12. Versmissen J., Botden I.P., Huijgen R., et al. Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality. Atherosclerosis 2011, 219:690-693.
13. Kusters D.M., Avis H.J., Braamskamp M.J., et al. Inheritance pattern of familial hypercholesterolemia and markers of cardiovascular risk. J. Lipid Res. 2013, 54:2543-2549.
14. van der Graaf A., Vissers M.N., Gaudet D., et al. Dyslipidemia of mothers with familial hypercholesterolemia deteriorates lipids in adult offspring. Arterioscler. Thromb. Vasc. Biol. 2010, 30:2673-2677.
15. Koeijvoets K.C., Rodenburg J., Hutten B.A., et al. Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial. Circulation 2005, 112:3168-3173.
16. Narverud I., Retterstøl K., Iversen P.O., et al. Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review. Atherosclerosis 2014, 235:299-309.
17. Hobbs H.H., Brown M.S., Goldstein J.L. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1992, 1:445-466.
18. Bhatnagar D. Diagnosis and screening for familial hypercholesterolaemia: finding the patients, finding the genes. Ann. Clin. Biochem. 2006, 43:441-456.
19. Core Team R. R: A Language and Environment for Statistical Computing 2014, R Foundation for Statistical Computing, Vienna, Austria, URL. http://www.R-project.org.
20. Guardamagna O., Restagno G., Rolfo E., et al. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia. J. Pediatr. 2009, 155. 199-204 e192.
21. Tonstad S., Joakimsen O., Leren T.P., Ose L. Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia?. Acta Paediatr. 2000, 89:1490-1492.
22. Narverud I., Iversen P.O., Aukrust P., et al. Maternal familial hypercholesterolemia (FH) confers altered hemostatic profile in offspring with and without FH. Thromb. Res. 2013, 131:178-182.
23. Toleikyte I., Retterstøl K., Leren T.P., Iversen P.O. Pregnancy outcomes in familial hypercholesterolemia: a registry-based study. Circulation 2011, 124:1606-1614.
24. Ten Kate G.J., Neefjes L.A., Dedic A., et al. The effect of LDLR-negative genotype on CT coronary atherosclerosis in asymptomatic statin treated patients with heterozygous familial hypercholesterolemia. Atherosclerosis 2013, 227:334-341.
25. Oosterveer D.M., Versmissen J., Yazdanpanah M., Hamza T.H., Sijbrands E.J. Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis. Atherosclerosis 2009, 207:311-317.
26. Holven K.B., Myhre A.M., Aukrust P., Hagve T.A., Ose L., Nenseter M.S. Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender. Eur. Heart J. 2003, 24:1756-1762.
27. Wiegman A., de Groot E., Hutten B.A., et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet 2004, 363:369-370.
28. Narverud I., Halvorsen B., Nenseter M.S., et al. Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia. J. Intern Med. 2013, 273:69-78.
29. Narverud I., Ueland T., Nenseter M.S., et al. Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor alpha system and interleukin-10. Atherosclerosis 2011, 214:163-168.